Literature DB >> 18034611

'Drug reactions, enzymes, and biochemical genetics': 50 years later.

David Gurwitz, Arno G Motulsky.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 18034611     DOI： 10.2217/14622416.8.11.1479

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN： 1462-2416            Impact factor:   2.533


× No keyword cloud information.
  9 in total

Review 1.  The Outlier in All of Us: Why Implementing Pharmacogenomics Could Matter for Everyone.

Authors:  P H O'Donnell; K Danahey; M J Ratain
Journal:  Clin Pharmacol Ther       Date:  2016-02-15       Impact factor: 6.875

2.  Group-based pharmacogenetic prediction: is it feasible and do current NHS England ethnic classifications provide appropriate data?

Authors:  Catherine J E Ingram; Rosemary Ekong; Naser Ansari-Pour; Neil Bradman; Dallas M Swallow
Journal:  Pharmacogenomics J       Date:  2020-07-18       Impact factor: 3.550

Review 3.  Pharmacogenomics in early-phase clinical development.

Authors:  Tal Burt; Savita Dhillon
Journal:  Pharmacogenomics       Date:  2013-07       Impact factor: 2.533

4.  PRECISION MEDICINE: FROM DIPLOTYPES TO DISPARITIES TOWARDS IMPROVED HEALTH AND THERAPIES.

Authors:  Dana C Crawford; Alexander A Morgan; Joshua C Denny; Bruce J Aronow; Steven E Brenner
Journal:  Pac Symp Biocomput       Date:  2018

5.  Risk assessment and communication tools for genotype associations with multifactorial phenotypes: the concept of "edge effect" and cultivating an ethical bridge between omics innovations and society.

Authors:  Vural Ozdemir; Guilherme Suarez-Kurtz; Raphaëlle Stenne; Andrew A Somogyi; Toshiyuki Someya; S Oğuz Kayaalp; Eugene Kolker
Journal:  OMICS       Date:  2009-02

6.  Automatic filtering and substantiation of drug safety signals.

Authors:  Anna Bauer-Mehren; Erik M van Mullingen; Paul Avillach; María Del Carmen Carrascosa; Ricard Garcia-Serna; Janet Piñero; Bharat Singh; Pedro Lopes; José L Oliveira; Gayo Diallo; Ernst Ahlberg Helgee; Scott Boyer; Jordi Mestres; Ferran Sanz; Jan A Kors; Laura I Furlong
Journal:  PLoS Comput Biol       Date:  2012-04-05       Impact factor: 4.475

7.  Prevalence of the CYP2D6*10 (C100T), *4 (G1846A), and *14 (G1758A) alleles among Iranians of different ethnicities.

Authors:  Ali Bagheri; Behnam Kamalidehghan; Maryam Haghshenas; Parisa Azadfar; Leila Akbari; Mohammad Hossein Sangtarash; Faramarz Vejdandoust; Fatemeh Ahmadipour; Goh Yong Meng; Massoud Houshmand
Journal:  Drug Des Devel Ther       Date:  2015-05-13       Impact factor: 4.162

8.  Pharmacogenomics, human genetic diversity and the incorporation and rejection of color/race in Brazil.

Authors:  Ricardo Ventura Santos; Gláucia Oliveira da Silva; Sahra Gibbon
Journal:  Biosocieties       Date:  2015-03-01

9.  Drug-induced acute myocardial infarction: identifying 'prime suspects' from electronic healthcare records-based surveillance system.

Authors:  Preciosa M Coloma; Martijn J Schuemie; Gianluca Trifirò; Laura Furlong; Erik van Mulligen; Anna Bauer-Mehren; Paul Avillach; Jan Kors; Ferran Sanz; Jordi Mestres; José Luis Oliveira; Scott Boyer; Ernst Ahlberg Helgee; Mariam Molokhia; Justin Matthews; David Prieto-Merino; Rosa Gini; Ron Herings; Giampiero Mazzaglia; Gino Picelli; Lorenza Scotti; Lars Pedersen; Johan van der Lei; Miriam Sturkenboom
Journal:  PLoS One       Date:  2013-08-28       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.